Norbert W. Bischofberger
2016
In 2016, Norbert W. Bischofberger earned a total compensation of $6.2M as Executive Vice President, Research and Development and Chief Scientific Officer at Gilead Sciences, a 11% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,179,544 |
|---|---|
| Option Awards | $1,999,964 |
| Salary | $1,044,231 |
| Stock Awards | $1,935,730 |
| Other | $10,000 |
| Total | $6,169,469 |
Bischofberger received $2M in option awards, accounting for 32% of the total pay in 2016.
Bischofberger also received $1.2M in non-equity incentive plan, $1M in salary, $1.9M in stock awards and $10K in other compensation.
Rankings
In 2016, Norbert W. Bischofberger's compensation ranked 1,146th out of 14,075 executives tracked by ExecPay. In other words, Bischofberger earned more than 91.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,146 out of 14,075 | 92nd |
Division Manufacturing | 387 out of 5,489 | 93rd |
Major group Chemicals And Allied Products | 103 out of 1,895 | 95th |
Industry group Drugs | 67 out of 1,538 | 96th |
Industry Biological Products, Except Diagnostic Substances | 12 out of 279 | 96th |
Source: SEC filing on March 26, 2018.
Bischofberger's colleagues
We found four more compensation records of executives who worked with Norbert W. Bischofberger at Gilead Sciences in 2016.